Position in TMO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$13,967,388
+$2,669,080 QoQ
Shares Held
27,859
+21.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
3.76%
of 13F equity value
Holder Rank
#568
of 2,606 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Atle Fund Management AB holds $13,967,388 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
27,859 | $13,967,388 |
All Filings in TMO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,967,388 | 27,859 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $11,298,308 | 22,986 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $17,334,246 | 29,915 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,397,844 | 27,147 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,838,892 | 24,266 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $11,373,643 | 22,857 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $12,951,646 | 24,896 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $13,615,962 | 22,012 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,760,274 | 19,458 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,826,255 | 15,186 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $6,058,967 | 11,415 | Shares | Sole | 2024-01-30 | |
| 2022-12-31 | $121,151 | 220 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||